Clinical trial
Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial…
NCT00019136 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00019136 |
|---|---|
| Title | Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer |
| Official title | TREATMENT OF PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER USING ANTI-CD3 STIMULATED PERIPHERAL BLOOD LYMPHOCYTES TRANSDUCED WITH A GENE ENCODING A CHIMERIC T-CELL RECEPTOR REACTIVE WITH FOLATE BINDING PROTEIN |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Biological |
| Interventions | MOv-gamma chimeric receptor gene, aldesleukin, therapeutic allogeneic lymphocytes |
| Start date | Feb 1, 1997 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 29, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: